January 20, 2021 Allergy/Immunology California investigating why less than 10 people at one specific vaccination site (but not anywhere else) developed possible allergic reactions from specific lot of Moderna vaccine. Was it the vaccine or some other source?
December 24, 2020 Allergy/Immunology NEJM study concludes that time required to determine Moderna’s effect on longevity of antibody, B and T cell response. However, the vaccine works. Worst-case scenario is that we will require a booster.
December 11, 2020 Allergy/Immunology Male sex identified as a risk factor for death and ICU admission due to Covid-19 infection. There are identified differences within components of the immune system that show women have more robust responses.
December 10, 2020 Allergy/Immunology Adverse allergic reactions reported with Pfizer vaccine was expected. Briefing documents showed 6/1000 in treatment group and 5/1000 in placebo group had allergic reactions. Vaccine eligibility will be refined after determining the nature of the reactions
December 2, 2020 Allergy/Immunology Antibody testing for COVID-19 may satisfy your curiosity and provide a false sense of protection but will not change the outcome of what we need to continue to do. Not enough is known about immunity duration or transmission potential after infection.
November 16, 2020 Allergy/Immunology Study shows ten percent of people, mostly men, with severe COVID-19, develop an autoimmune response that attacks interferons (part of the immune system) thereby reducing the host’s ability to defend against the virus.
November 4, 2020 Allergy/Immunology The new and improved triple-layer face mask! You do not have to throw out your old one. It still works. Plus, small unpublished study on T-cell response reports that it is still present six months after Covid infection.
October 30, 2020 Allergy/Immunology Study reports that people who had mild to moderate #COVID-19 have protective stable antibody levels five months after their infection. This finding and further studies to follow can help with public policy and vaccine development programs.
October 29, 2020 Allergy/Immunology Vulnerable populations to be the focus in a new Canadian COVID-19 antibody study.
October 14, 2020 Allergy/Immunology It is too soon to draw any conclusions about short/long term immunity based on COVID-19 antibody levels. Many unknown factors remain. Time should help with the answers in future studies.